These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rethinking oxidized low-density lipoprotein, its role in atherogenesis and the immune responses associated with it. Shaw PX Arch Immunol Ther Exp (Warsz); 2004; 52(4):225-39. PubMed ID: 15467487 [TBL] [Abstract][Full Text] [Related]
8. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027 [TBL] [Abstract][Full Text] [Related]
9. Antibodies to oxidized LDL in atherosclerosis development--clinical and animal studies. Hulthe J Clin Chim Acta; 2004 Oct; 348(1-2):1-8. PubMed ID: 15369729 [TBL] [Abstract][Full Text] [Related]
11. Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity. Shaw PX; Hörkkö S; Chang MK; Curtiss LK; Palinski W; Silverman GJ; Witztum JL J Clin Invest; 2000 Jun; 105(12):1731-40. PubMed ID: 10862788 [TBL] [Abstract][Full Text] [Related]
12. Are immunological mechanisms relevant for the development of atherosclerosis? Witztum JL; Palinski W Clin Immunol; 1999 Feb; 90(2):153-6. PubMed ID: 10080825 [No Abstract] [Full Text] [Related]